Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma

Figure 2

PET-CT showing (a) lymph node metastasis near the bifurcation of trachea and lumbar vertebral metastasis before sorafenib rechallenge therapy and (b) that the metastatic lesion vanished 5 months after the rechallenge therapy.

(a)

(b)